Mokita Medical GmbH

Key facts about Mokita:

•Company established in 2017 based on medical need identified in clinical practice

•Medical device for supportive use in established markets for major cardiovascular interventions

•Addressable market size for large bore cardiovascular devices expected:  ≥1bio€ in 2030

•Prevention of serious brain injury due to gaseous embolization, a previously overlooked major problem

•Rapidly increasing awareness of serious medical need: market needs innovation to solve problem

•Development phase: functional prototype to be finalized to an automated commercial device

•Regulatory pathway prepared (US and EU), Commercial launch: as from 2027 to selected centers

•Comprehensive patent protection, 7 patent families, 11 patents granted

•Current financial need: 4.0mio€, Previous investments: 1.5mio€ (mostly clinical experts)